XML 58 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Unaudited Condensed Consolidated Statement of Cash Flows Statement - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 222,598 $ 254,322
Adjustments to reconcile net income to net cash provided by operating activities:    
Losses on early extinguishment of debt, net (16,637) (10,131)
Depreciation and amortization 112,616 117,496
Amortization of intangibles 19,374 20,170
Amortization of cemetery property 48,648 47,509
Amortization of loan costs 4,410 4,531
Provision for doubtful accounts 6,886 6,522
Provision for deferred income taxes 18,335 25,491
Losses (gains) on divestitures and impairment charges, net 15,180 (15,317)
Gain (Loss) on Sale of Investments 0 (2,636)
Share-based compensation 11,563 11,740
Change in assets and liabilities, net of effects from acquisitions and divestitures:    
Increase in receivables (6,030) (964)
Increase in other assets (22,499) (19,251)
Decrease in payables and other liabilities (16,023) (2,879)
Effect of preneed production and maturities:    
Decrease (increase) in preneed receivables, net and trust investments 1,055 (37,387)
Increase in deferred revenue, net 56,078 43,329
Decrease in deferred receipts held in trust (16,631) (10,541)
Net cash provided by operating activities 472,197 452,266
Cash flows from investing activities:    
Capital expenditures (177,173) (165,943)
Acquisitions, net of cash acquired 67,441 (187,616)
Proceeds from divestitures and sales of property and equipment 13,949 29,890
Proceeds from Sale, Maturity and Collection of Investments 0 2,900
Payments on Company-owned life insurance policies (9,017) (14,283)
Proceeds from Company-owned life insurance policies 0 2,810
Other 0 (14,525)
Net cash used in investing activities (239,682) (346,767)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 1,089,263 395,000
Payments of Debt Issuance Costs 15,537 0
Scheduled payments of debt (16,906) (25,601)
Early payments of debt (1,164,977) (259,590)
Principal payments on finance leases 32,258 29,771
Proceeds from exercise of stock options 39,831 18,481
Purchase of Company common stock (52,183) (275,726)
Payments of dividends (98,581) (93,002)
Bank overdrafts and other 9,341 (8,842)
Net cash used in financing activities (242,007) (279,051)
Effect of foreign currency on cash, cash equivalents, and restricted cash 2,201 (1,111)
Net decrease in cash, cash equivalents, and restricted cash (7,291) (174,663)
Cash, cash equivalents, and restricted cash at beginning of period 207,584 340,601
Cash, cash equivalents, and restricted cash at end of period $ 200,293 $ 165,938